DEA Okays First Medical Marijuana Trials in Nearly Two Decades 12/14/01

Drug War Chronicle, recent top items


recent blog posts "In the Trenches" activist feed


(courtesy NORML Foundation,

Washington, DC: Drug Enforcement Administration (DEA) officials recently gave final approval for three state-sponsored patient trials on the therapeutic potential of smoked marijuana. The decision reverses a nearly two decade federal de facto prohibition on medical marijuana research.

All three patient trials will take place at the University of California's Center for Medicinal Cannabis Research (CMCR), headquartered at the Universities of California at San Diego (UCSD) and San Francisco (UCSF).

One study will examine the safety and efficacy of smoked marijuana versus placebo for the alleviation of peripheral nerve pain associated with HIV infection. Another will examine the efficacy of inhaled marijuana versus placebo for the treatment of muscle spasticity in Multiple Sclerosis patients.

A sub-study of the latter cohort will also examine the impact of marijuana on psychomotor skills using driving simulator assessments. Each study will use federally supplied marijuana from the National Institute on Drug Abuse (NIDA).

Patient recruitment for the trials is expected to begin early next year. Patients interested in participating in the studies should visit the CMCR website at for more information.

The CMCR, established in August 2000 and funded by the state of California, supports and coordinates research assessing the use of cannabis as a medicine.

Last February, the Center's independent Scientific Review Board approved four medi-pot clinical trials. After more than nine months of review, federal regulatory agencies and the DEA have finally signed off on three of the trials.

The fourth -- a proposed inpatient study on the effectiveness of smoked marijuana on HIV-related neuropathy by noted UCSF AIDS researcher Dr. Donald Abrams -- still awaits final approval from the DEA, though a CMCR spokeswoman said that they expect authorization for that study within a matter of weeks.

Abrams has been attempting to gain federal permission to conduct such a study for more than five years. A previous study by Abrams found that smoked marijuana does not disrupt the effectiveness of anti-retroviral drugs in HIV patients. Subjects who smoked marijuana in the study were also found to have gained significantly more weight on average than those receiving placebo, and had slightly lower viral levels.

Presently, seven additional FDA and NIDA-approved medical marijuana studies -- including three on cannabis and analgesia -- are also awaiting approval from the DEA. It remains uncertain if and when the DEA will approve the research, without which none of the clinical trials may move forward. Of the recently approved protocols, all three received FDA and NIDA authorization to proceed several months before the DEA finally endorsed them.

Visit for further information on the CMCR's clinical research trials.

-- END --
Link to Drug War Facts
Please make a generous donation to support Drug War Chronicle in 2007!          

PERMISSION to reprint or redistribute any or all of the contents of Drug War Chronicle (formerly The Week Online with DRCNet is hereby granted. We ask that any use of these materials include proper credit and, where appropriate, a link to one or more of our web sites. If your publication customarily pays for publication, DRCNet requests checks payable to the organization. If your publication does not pay for materials, you are free to use the materials gratis. In all cases, we request notification for our records, including physical copies where material has appeared in print. Contact: the Drug Reform Coordination Network, P.O. Box 18402, Washington, DC 20036, (202) 293-8340 (voice), (202) 293-8344 (fax), e-mail [email protected]. Thank you.

Articles of a purely educational nature in Drug War Chronicle appear courtesy of the DRCNet Foundation, unless otherwise noted.

Issue #215, 12/14/01 Do You Read the Week Online? | Top British Cops Call for Legal Heroin for Addicts, Liberal Democrats Join Growing Ecstasy Rescheduling Chorus | Marijuana Arrests Fuel Increase in Teen Drug Treatment Numbers | DEA Dog and Pony Show on Narcoterror Rallies Drug Warriors, Initiates New Propaganda Campaign | Narco News Lawsuit Thrown Out: Precedent Extends Press Protections to the Internet | Bolivian Cocaleros Call for Pause in Blockades | Catholic Progressives Differ with Pope on Drug Prohibition | Utah Town Makes Marijuana Possession Ten Dollar Fine, Draws Heat, Will Retreat | DEA Okays First Medical Marijuana Trials in Nearly Two Decades | Book Review: "Narcocorridos: A Journey Into the Music of Drugs, Guns, and Guerrillas" | Media/Web Scan: Mother Jones,, Essence, Reason, ColorLines, FPIF Report, FEAR Manual, Hutchinson-Johnson Debate | Bay Area: Job Opportunity at Harm Reduction Coalition | Alerts: Bolivia, HEA Drug Provision, Sembler Nomination, DEA Hemp Ban, Ecstasy Bill, Mandatory Minimums, Medical Marijuana | The Reformer's Calendar
Mail this article to a friend
Send us feedback on this article
This issue -- main page
This issue -- single-file printer version
Drug War Chronicle -- main page
Chronicle archives
Subscribe now!
Out from the Shadows HEA Drug Provision Drug War Chronicle Perry Fund DRCNet en EspaŮol Speakeasy Blogs About Us Home
Why Legalization? NJ Racial Profiling Archive Subscribe Donate DRCNet em PortuguÍs Latest News Drug Library Search
special friends links: SSDP - Flex Your Rights - IAL - Drug War Facts the Drug Reform Coordination Network (DRCNet)
1623 Connecticut Ave., NW, 3rd Floor, Washington DC 20009 Phone (202) 293-8340 Fax (202) 293-8344 [email protected]